Correlation Between ExpreS2ion Biotech and Hansa Biopharma

Can any of the company-specific risk be diversified away by investing in both ExpreS2ion Biotech and Hansa Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ExpreS2ion Biotech and Hansa Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ExpreS2ion Biotech Holding and Hansa Biopharma AB, you can compare the effects of market volatilities on ExpreS2ion Biotech and Hansa Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ExpreS2ion Biotech with a short position of Hansa Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of ExpreS2ion Biotech and Hansa Biopharma.

Diversification Opportunities for ExpreS2ion Biotech and Hansa Biopharma

0.2

Correlation Coefficient

ExpreS2ion Biotech  Hansa Biopharma

Modest diversification

The 3 months correlation between ExpreS2ion and Hansa is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding ExpreS2ion Biotech Holding and Hansa Biopharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hansa Biopharma AB and ExpreS2ion Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ExpreS2ion Biotech Holding are associated (or correlated) with Hansa Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hansa Biopharma AB has no effect on the direction of ExpreS2ion Biotech i.e., ExpreS2ion Biotech and Hansa Biopharma go up and down completely randomly.

Pair Corralation between ExpreS2ion Biotech and Hansa Biopharma

Assuming the 90 days trading horizon ExpreS2ion Biotech Holding is expected to generate 1.57 times more return on investment than Hansa Biopharma. However, ExpreS2ion Biotech is 1.57 times more volatile than Hansa Biopharma AB. It trades about 0.09 of its potential returns per unit of risk. Hansa Biopharma AB is currently generating about 0.08 per unit of risk. If you would invest  1,940  in ExpreS2ion Biotech Holding on April 22, 2025 and sell it today you would earn a total of  555.00  from holding ExpreS2ion Biotech Holding or generate 28.61% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

ExpreS2ion Biotech Holding  vs.  Hansa Biopharma AB

ExpreS2ion Biotech

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in ExpreS2ion Biotech Holding are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, ExpreS2ion Biotech sustained solid returns over the last few months and may actually be approaching a breakup point.

Hansa Biopharma AB

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Hansa Biopharma AB are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Hansa Biopharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with ExpreS2ion Biotech and Hansa Biopharma

The main advantage of trading using opposite ExpreS2ion Biotech and Hansa Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ExpreS2ion Biotech position performs unexpectedly, Hansa Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hansa Biopharma will offset losses from the drop in Hansa Biopharma's long position.

The idea behind ExpreS2ion Biotech Holding and Hansa Biopharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.